• Source: Koronis Pharmaceuticals

Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998. Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection. The company also has products in development for the treatment of hepatitis C and RSV infection.




References






External links


Official website
Reuters story on IPO prospects [1]

Kata Kunci Pencarian:

• Koronis Pharmaceuticals
• Koronis
• Greek Muslims